Thiamine is a B vitamin, also known as vitamin B1. A deficiency of thiamine can lead to a range of symptoms, including weakness, fatigue and nerve problems. As it is not stored in the body, it is important to ensure that adequate thiamine intake is obtained from food, and if this is not enough, dietary supplements or medication can be used. Thiamine can be found in pharmaceutical forms such as capsules, tablets, film-coated tablets, oral solutions and injectable solutions.
The selected active substance is characterised by its bitter taste, which is why we tried to mask it in our study. For this purpose, two primary samples were produced, in which thiamine chloride was incorporated and the resulting granules were then coated with a polymeric coating to mask the taste. In the first experiment, Syloid® 244FP and GALENIQ 800 were made into granules and the active ingredient was incorporated, while in the second experiment the active ingredient was incorporated directly into Syloid® 244FP. The coating polymer chosen was a methacrylic acid copolymer (Eudragit® E PO), which was applied to the granules in different concentrations and quantities to obtain granules that were more or less coated.
After coating the granules, the release of the active substance was evaluated mainly in pH 1,2 medium, in which the applied polymeric coating dissolves, and in pH 6,8 medium, in which the polymeric coating does not dissolve. In this way, we checked whether our coating was effective and whether we were able to mask the bitter taste of the active substance. The experiment where we incorporated the active substance into the Syloid® 244FP itself and added a higher proportion of the coating proved to be a more optimal process from the point of view of the coating, but still the delay in the release of the active substance was not perfect, as was also evident from the images we took with the in-line electron microscope.
As conventional dosage forms are not suitable for pediatric and geriatric patients, and injectable solutions are often a very invasive method of drug administration, we decided to try to make an orodispersible thiamine chloride tablet from coated granules. In terms of the physical properties of the samples made, we chose a sample made from Syloid® 244FP and GALENIQ 800 granules of the active substance and coated with two different concentrations of the polymer coating to produce an orodispersible tablet. In the end, we managed to produce an orodispersible tablet that contained, in addition to the primary granules, a disintegrant and a binder.
|